Currently, there are 7.56B common shares owned by the public and among those 7.52B shares have been available to trade.
The company’s stock has a 5-day price change of 6.94% and -4.83% over the past three months. BAC shares are trading 1.68% year to date (YTD), with the 12-month market performance up to 16.11% higher. It has a 12-month low price of $33.06 and touched a high of $48.08 over the same period. BAC has an average intraday trading volume of 49.49 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.75%, 11.06%, and 5.37% respectively.
Institutional ownership of Bank Of America Corp (NYSE: BAC) shares accounts for 75.46% of the company’s 7.56B shares outstanding.
It has a market capitalization of $336.60B and a beta (3y monthly) value of 1.31. The stock’s trailing 12-month PE ratio is 13.34, while the earnings-per-share (ttm) stands at $3.35. The company has a PEG of 0.94 and the debt-to-equity ratio at 2.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.28% over the week and 2.08% over the month.
Analysts forecast that Bank Of America Corp (BAC) will achieve an EPS of 0.89 for the current quarter, 0.93 for the next quarter and 4.22 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.85 while analysts give the company a high EPS estimate of 0.85. Comparatively, EPS for the current quarter was 0.83 a year ago. Earnings per share for the fiscal year are expected to increase by 13.61%, and 16.59% over the next financial year. EPS should grow at an annualized rate of 14.13% over the next five years, compared to 3.14% over the past 5-year period.
Looking at the support for the BAC, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on May 15, 2025, with the firm’s price target at $53. Morgan Stanley coverage for the Bank Of America Corp (BAC) stock in a research note released on April 07, 2025 offered a Overweight rating with a price target of $47. Robert W. Baird was of a view on March 07, 2025 that the stock is Outperform, while UBS gave the stock Buy rating on January 07, 2025, issuing a price target of $43- $53. HSBC Securities on their part issued Buy rating on January 07, 2025.
